0 التعليقات
0 المشاركات
649 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Expanding Oncology Demand Boosts Immune Checkpoint Inhibitors Market ValueImmune checkpoint inhibitors are cutting-edge immunotherapies that strengthen the body’s natural defense mechanisms by inhibiting proteins that prevent immune cells from attacking cancer. By blocking checkpoints such as CTLA 4 and PD 1/PD L1, these treatments enhance T cell activation and tumor destruction. Their expanding clinical success is driving broader integration into combination...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
First-in-Class Oncology Drug Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Global Executive Summary First-in-Class Oncology Drug Market: Size, Share, and Forecast The global first-in-class oncology drug market size was valued at USD 8.67 billion in 2025 and is expected to reach USD 25.08 billion by 2033, at a CAGR of14.20% during the forecast periodThe market growth is largely fueled by rapid advancements in drug discovery technologies, high unmet medical needs...0 التعليقات 0 المشاركات 110 مشاهدة 0 معاينة
-
First-in-Class Oncology Drug Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Key Drivers Impacting Executive Summary First-in-Class Oncology Drug Market Market Size and Share The global first-in-class oncology drug market size was valued at USD 8.67 billion in 2025 and is expected to reach USD 25.08 billion by 2033, at a CAGR of14.20% during the forecast periodThe market growth is largely fueled by rapid advancements in drug discovery technologies, high unmet...0 التعليقات 0 المشاركات 528 مشاهدة 0 معاينة
-
How Are Oncology Treatment Innovations Boosting the Europe Tumor Ablation Market?Global Executive Summary Europe Tumor Ablation Market: Size, Share, and Forecast CAGR Value The Europe tumor ablation market size was valued at USD 584.50 million in 2025 and is expected to reach USD 1,349.91 million by 2033, at a CAGR of 11.03% during the forecast period The Europe Tumor Ablation Market analysis report focuses on leading global industry players, providing information such...0 التعليقات 0 المشاركات 651 مشاهدة 0 معاينة
-
Is the Epigenetics-Based Therapeutics Market Transforming Precision Medicine and Oncology?"Executive Summary Epigenetics-Based Therapeutics Market Research: Share and Size Intelligence CAGR Value The global epigenetics-based therapeutics market size was valued at USD 1.76 billion in 2024 and is expected to reach USD 5.17 billion by 2032, at a CAGR of 14.40% during the forecast period The all-inclusive Epigenetics-Based Therapeutics Market...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Is the Global Colorectal Cancer Treatment Market Advancing with Breakthrough Oncology Therapies?Executive Summary Colorectal Cancer Treatment Market Size and Share Across Top Segments CAGR Value Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Market drivers and market restraints...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
mTOR Inhibitor Oncology Drug Market Grows with Breakthroughs in Targeted Cancer Therapy"Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share Forecast CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period Competitive analysis performed in this mTOR Inhibitor Oncology Drug Market...0 التعليقات 0 المشاركات 724 مشاهدة 0 معاينة
-
Oncology Small Molecule Drugs Market Growth Factors, Opportunities, Drivers, Strategies, Trends, and Forecast to 2031The Oncology Small Molecule Drugs Market is experiencing accelerated interest and investment as global healthcare systems intensify efforts to improve cancer care outcomes. According to the Oncology Small Molecule Drugs Market report by The Insight Partners, this market is anticipated to grow at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2031, underscoring sustained momentum in...0 التعليقات 0 المشاركات 668 مشاهدة 0 معاينة
-
Oral HER Pathway Targeted Drugs Market Advances with Precision Oncology Breakthroughs"Executive Summary Oral HER Pathway Targeted Drugs Market Research: Share and Size Intelligence CAGR Value The global oral HER pathway targeted drugs market size was valued at USD 6.24 billion in 2025 and is expected to reach USD 15.01 billion by 2033, at a CAGR of 11.60% during the forecast period This Oral HER Pathway Targeted Drugs Market research...0 التعليقات 0 المشاركات 676 مشاهدة 0 معاينة
-
Radiation Oncology Treatment Planning Software Market Advances with AI Integration"In-Depth Study on Executive Summary Radiation Oncology Treatment Planning Software Market Size and Share CAGR Value Data Bridge Market Research analyses that the radiation oncology treatment planning software market which was USD 2.18 billion in 2022, would rocket up to USD 4.34 billion by 2030, and is expected to undergo a CAGR of 9.00% during the forecast period 2023 to 2030...0 التعليقات 0 المشاركات 227 مشاهدة 0 معاينة
-
Rising Demand in Oncology Therapeutics: Oncology Small Molecule Drugs Market Trends, Demand Analysis, and Forecast to 2031The Oncology Small Molecule Drugs Market is witnessing sustained growth as the global healthcare landscape continues to prioritize effective cancer treatment solutions. Small molecule drugs have become integral to oncology due to their ability to penetrate cells and target specific molecular pathways associated with tumor progression. These therapies are widely used across multiple cancer...0 التعليقات 0 المشاركات 137 مشاهدة 0 معاينة
-
5-Fluorouracil Market Outlook 2031: Growth Trends, Industry Dynamics, and Strategic OpportunitiesThe global 5-Fluorouracil market is witnessing steady expansion, driven by the increasing prevalence of cancer and the continued reliance on chemotherapy-based treatment protocols. 5-Fluorouracil (5-FU) remains one of the most widely used antimetabolite drugs in oncology, particularly for colorectal, breast, and gastrointestinal cancers. According to The Insight Partners, the market is expected...0 التعليقات 0 المشاركات 760 مشاهدة 0 معاينة
-
Antibody Drug Conjugates Market Expansion with New Cancer TherapiesNorth America currently holds a significant share in the antibody drug conjugates market due to strong research infrastructure and high healthcare spending. The presence of major pharmaceutical companies also supports regional growth. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 التعليقات 0 المشاركات 849 مشاهدة 0 معاينة
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 التعليقات 0 المشاركات 96 مشاهدة 0 معاينة
-
CAR-T Cell Therapy Market Demand Rising Across Global HealthcareExpanding healthcare infrastructure in emerging economies is creating new opportunities for the CAR-T cell therapy market. Countries in Asia-Pacific and Latin America are investing in advanced cancer treatment facilities. This expansion supports global market growth. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030 with 17.5% CAGR The global CAR-T Cell Therapy Market is witnessing...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 التعليقات 0 المشاركات 761 مشاهدة 0 معاينة
-
Chemotherapy Induced Anemia Market Size, Trends, and Growth StrategiesThe chemotherapy induced anemia market is witnessing steady growth driven by rising cancer prevalence and advancements in anemia management therapies. Increasing demand for effective anemia treatment options and enhanced diagnostic capabilities are reshaping market dynamics, with notable shifts in market trends poised to influence business growth globally.Market Size and Overview The...0 التعليقات 0 المشاركات 762 مشاهدة 0 معاينة
-
Dendritic Cell Cancer Vaccine Market Opportunities in Precision MedicinePharmaceutical companies are expanding their oncology pipelines to include dendritic cell vaccine therapies. Continuous research is leading to the discovery of new therapeutic targets. These advancements are strengthening the market. The Dendritic Cell Cancer Vaccine Market is gaining significant attention in the global oncology landscape as immunotherapy continues to revolutionize cancer...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Expanding Horizons in Adult Malignant Glioma Therapeutics Market: Growth Opportunities, Strategies, and Forecast to 2031The global oncology sector is undergoing a significant transformation, driven by the rising prevalence of aggressive brain tumors such as malignant gliomas in adults. Increasing incidence rates, coupled with advancements in immunotherapy, targeted therapies, and precision medicine, are shaping a dynamic treatment landscape. Pharmaceutical and biotechnology companies are focusing on developing...0 التعليقات 0 المشاركات 347 مشاهدة 0 معاينة
الصفحات المعززة
إعلان مُمول
إعلان مُمول
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek